Henk V.

Entrepreneur & CXO | Life Sciences & Biotech

Netherlands
EN

Dr. Henk Viëtor is owner of DDF Ventures, FFUND and Nebula Participations. Henk is an active entrepreneur in the life sciences industry and has (co-)founded several biotechnology companies, including ...see more

  • Biotechnology & Life Sciences

450

/hr
  • Pre-vetted expert
  • Confirmed hourly rate
  • Available on short notice

Experience

CMO

DC4U
3 years
Current position
Dec 2018 - Present
DC4U is a life science company developing technologies that enable steering the human immune response.

CTO

Qurin Diagnostics
5 years
Current position
Oct 2017 - Present
At Qurin Diagnostics we are developing a low threshold and noninvasive test for cancer with state-of-the art nanotechnology to detect biomarkers.

Partner

FFUND
6 years
Current position
Aug 2016 - Present
FFUND is a full-service consultancy firm, aiding innovative businesses in the Health and Life Sciences to grow by securing dilutive and non-dilutive funding. Find out more on www.ffund...see more

Owner

DDF ventures
3 years
Dec 2015 - May 2019
DDF Ventures manages and finances the development of a selected portfolio of promising early stage life-sciences companies.The company presently holds 5 companies in portfolio including...see more

CEO

Oncodrone
5 years
Oct 2013 - Feb 2019
Oncodrone develops life prolonging drugs for patients with advanced prostate cancer.

CEO

Skyline Diagnostics BV
7 years
Dec 2004 - Dec 2011
Henk was CEO of Skyline Diagnostics until September 1, 2012 and is now on the Supervisory Board of the Company as industry expert.

Managing Director

Drug Discovery Factory
12 years
Jul 2003 - Dec 2015

Owner

Drug Discovery Factory
13 years
Dec 2002 - Dec 2015
Henk and Peter Schoevers are Managing directors of Drug Discovery Factory.

Industries, roles and expertise

Industry experience

  • Biotechnology & Life Sciences

Expertise

  • Commercialization
  • Oncology
  • Cancer
  • Molecular Biology
  • Genomics
  • Immunology
  • Genetics
  • Diagnostics
  • Cell